MICHAEL JAY ROSS Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for MICHAEL JAY ROSS.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of MICHAEL JAY ROSS. MICHAEL JAY ROSS is Director in SUTRO BIOPHARMA INC ($STRO) and Director in Ophthotech Corp. ($OPHT) and Director in CATABASIS PHARMACEUTICALS INC ($CATB) and Director in Arsanis, Inc. ($ASNS) and Director in Deciphera Pharmaceuticals, Inc. ($DCPH).
Latest Insider Trading Transactions of MICHAEL JAY ROSS
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, CATB, DCPH, OPHT, STRO, ASNS
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 13 2019 | DCPH | Deciphera Pharmace ... | Ross Michael Jay | Director | Option Exercise | A | 21.05 | 12,000 | 252,600 | 12,000 | |
| Oct 01 2018 | STRO | SUTRO BIOPHARMA IN ... | Ross Michael Jay | Director | Option Exercise | C | 0.00 | 193,492 | 0 | 0 | |
| Oct 01 2018 | STRO | SUTRO BIOPHARMA IN ... | Ross Michael Jay | Director | Option Exercise | C | 0.00 | 141,249 | 0 | 0 | |
| Oct 01 2018 | STRO | SUTRO BIOPHARMA IN ... | Ross Michael Jay | Director | Option Exercise | C | 0.00 | 194,786 | 0 | 0 | |
| Oct 01 2018 | STRO | SUTRO BIOPHARMA IN ... | Ross Michael Jay | Director | Option Exercise | C | 0.00 | 9,155,794 | 0 | 0 | |
| Oct 01 2018 | STRO | SUTRO BIOPHARMA IN ... | Ross Michael Jay | Director | Option Exercise | C | 0.00 | 6,683,697 | 0 | 0 | |
| Oct 01 2018 | STRO | SUTRO BIOPHARMA IN ... | Ross Michael Jay | Director | Option Exercise | C | 0.00 | 9,217,015 | 0 | 0 | |
| Oct 01 2018 | STRO | SUTRO BIOPHARMA IN ... | Ross Michael Jay | Director | Option Exercise | C | 0.00 | 52,183 | 0 | 0 | |
| Oct 01 2018 | STRO | SUTRO BIOPHARMA IN ... | Ross Michael Jay | Director | Option Exercise | C | 0.00 | 106,019 | 0 | 0 | |
| Oct 01 2018 | STRO | SUTRO BIOPHARMA IN ... | Ross Michael Jay | Director | Option Exercise | C | 0.00 | 17,533 | 0 | 0 | |
| Oct 01 2018 | STRO | SUTRO BIOPHARMA IN ... | Ross Michael Jay | Director | Option Exercise | C | 0.00 | 5,462,550 | 0 | 0 | |
| Oct 01 2018 | STRO | SUTRO BIOPHARMA IN ... | Ross Michael Jay | Director | Option Exercise | C | 0.00 | 11,097,596 | 0 | 0 | |
| Oct 01 2018 | STRO | SUTRO BIOPHARMA IN ... | Ross Michael Jay | Director | Option Exercise | C | 0.00 | 1,835,270 | 0 | 0 | |
| Oct 01 2018 | STRO | SUTRO BIOPHARMA IN ... | Ross Michael Jay | Director | Option Exercise | C | 0.00 | 64,815 | 0 | 0 | |
| Oct 01 2018 | STRO | SUTRO BIOPHARMA IN ... | Ross Michael Jay | Director | Option Exercise | C | 0.00 | 131,683 | 0 | 0 | |
| Oct 01 2018 | STRO | SUTRO BIOPHARMA IN ... | Ross Michael Jay | Director | Option Exercise | C | 0.00 | 21,776 | 0 | 0 | |
| Oct 01 2018 | STRO | SUTRO BIOPHARMA IN ... | Ross Michael Jay | Director | Option Exercise | M | 0.00 | 4,978 | 0 | 52,183 | |
| Oct 01 2018 | STRO | SUTRO BIOPHARMA IN ... | Ross Michael Jay | Director | Option Exercise | M | 0.48 | 4,978 | 2,388 | 4,315 | |
| Oct 01 2018 | STRO | SUTRO BIOPHARMA IN ... | Ross Michael Jay | Director | Option Exercise | M | 0.00 | 521,159 | 0 | 5,462,550 | |
| Oct 01 2018 | STRO | SUTRO BIOPHARMA IN ... | Ross Michael Jay | Director | Option Exercise | M | 0.48 | 521,159 | 250,000 | 451,869 | |
| Oct 01 2018 | STRO | SUTRO BIOPHARMA IN ... | Ross Michael Jay | Director | Option Exercise | M | 0.00 | 6,183 | 0 | 64,815 | |
| Oct 01 2018 | STRO | SUTRO BIOPHARMA IN ... | Ross Michael Jay | Director | Option Exercise | M | 0.48 | 6,183 | 2,966 | 5,361 | |
| Oct 01 2018 | STRO | SUTRO BIOPHARMA IN ... | Ross Michael Jay | Director | Buy | C | 0.00 | 5,320 | 0 | 18,248 | 12.9 K to 18.2 K (+41.15 %) |
| Oct 01 2018 | STRO | SUTRO BIOPHARMA IN ... | Ross Michael Jay | Director | Buy | C | 0.00 | 5,721 | 0 | 12,928 | 7.2 K to 12.9 K (+79.38 %) |
| Oct 01 2018 | STRO | SUTRO BIOPHARMA IN ... | Ross Michael Jay | Director | Buy | C | 0.00 | 7,207 | 0 | 7,207 | 0 to 7.2 K |
| Oct 01 2018 | STRO | SUTRO BIOPHARMA IN ... | Ross Michael Jay | Director | Buy | C | 0.00 | 251,783 | 0 | 863,503 | 611.7 K to 863.5 K (+41.16 %) |
| Oct 01 2018 | STRO | SUTRO BIOPHARMA IN ... | Ross Michael Jay | Director | Buy | C | 0.00 | 270,690 | 0 | 611,720 | 341 K to 611.7 K (+79.37 %) |
| Oct 01 2018 | STRO | SUTRO BIOPHARMA IN ... | Ross Michael Jay | Director | Buy | C | 0.00 | 341,030 | 0 | 341,030 | 0 to 341 K |
| Oct 01 2018 | STRO | SUTRO BIOPHARMA IN ... | Ross Michael Jay | Director | Buy | C | 0.00 | 1,931 | 0 | 8,817 | 6.9 K to 8.8 K (+28.04 %) |
| Oct 01 2018 | STRO | SUTRO BIOPHARMA IN ... | Ross Michael Jay | Director | Buy | C | 0.00 | 6,128 | 0 | 6,886 | 758 to 6.9 K (+808.44 %) |
| Oct 01 2018 | STRO | SUTRO BIOPHARMA IN ... | Ross Michael Jay | Director | Buy | C | 0.00 | 758 | 0 | 758 | 0 to 758 |
| Oct 01 2018 | STRO | SUTRO BIOPHARMA IN ... | Ross Michael Jay | Director | Buy | C | 0.00 | 202,115 | 0 | 923,022 | 720.9 K to 923 K (+28.04 %) |
| Oct 01 2018 | STRO | SUTRO BIOPHARMA IN ... | Ross Michael Jay | Director | Buy | C | 0.00 | 641,440 | 0 | 720,907 | 79.5 K to 720.9 K (+807.18 %) |
| Oct 01 2018 | STRO | SUTRO BIOPHARMA IN ... | Ross Michael Jay | Director | Buy | C | 0.00 | 79,467 | 0 | 79,467 | 0 to 79.5 K |
| Oct 01 2018 | STRO | SUTRO BIOPHARMA IN ... | Ross Michael Jay | Director | Buy | C | 0.00 | 2,399 | 0 | 10,952 | 8.6 K to 11 K (+28.05 %) |
| Oct 01 2018 | STRO | SUTRO BIOPHARMA IN ... | Ross Michael Jay | Director | Buy | C | 0.00 | 7,610 | 0 | 8,553 | 943 to 8.6 K (+807.00 %) |
| Oct 01 2018 | STRO | SUTRO BIOPHARMA IN ... | Ross Michael Jay | Director | Buy | C | 0.00 | 943 | 0 | 943 | 0 to 943 |
| Sep 27 2018 | STRO | SUTRO BIOPHARMA IN ... | Ross Michael Jay | Director | Option Exercise | A | 15.00 | 26,033 | 390,495 | 26,033 | |
| Jul 11 2018 | OPHT | Ophthotech Corp. | Ross Michael Jay | Director | Option Exercise | A | 2.78 | 16,000 | 44,400 | 16,000 | |
| Jun 07 2018 | CATB | CATABASIS PHARMACE ... | Ross Michael Jay | Director | Option Exercise | A | 1.48 | 14,000 | 20,720 | 14,000 | |
| Jun 07 2018 | ASNS | Arsanis, Inc. | Ross Michael Jay | Director | Option Exercise | A | 16.99 | 10,000 | 169,900 | 10,000 | |
| May 21 2018 | DCPH | Deciphera Pharmace ... | Ross Michael Jay | Director | Option Exercise | A | 25.73 | 12,000 | 308,760 | 12,000 | |
| Dec 01 2017 | ASNS | Arsanis, Inc. | Ross Michael Jay | Director | Option Exercise | A | 10.00 | 7,324 | 73,240 | 7,324 | |
| Nov 20 2017 | ASNS | Arsanis, Inc. | Ross Michael Jay | Director | Option Exercise | C | 0.00 | 50,477 | 0 | 0 | |
| Nov 20 2017 | ASNS | Arsanis, Inc. | Ross Michael Jay | Director | Option Exercise | C | 0.00 | 1,474,348 | 0 | 0 | |
| Nov 20 2017 | ASNS | Arsanis, Inc. | Ross Michael Jay | Director | Option Exercise | C | 0.00 | 14,635 | 0 | 0 | |
| Nov 20 2017 | ASNS | Arsanis, Inc. | Ross Michael Jay | Director | Option Exercise | C | 0.00 | 692,552 | 0 | 0 | |
| Nov 20 2017 | ASNS | Arsanis, Inc. | Ross Michael Jay | Director | Option Exercise | C | 0.00 | 4,747 | 0 | 0 | |
| Nov 20 2017 | ASNS | Arsanis, Inc. | Ross Michael Jay | Director | Option Exercise | C | 0.00 | 224,665 | 0 | 0 | |
| Nov 20 2017 | ASNS | Arsanis, Inc. | Ross Michael Jay | Director | Option Exercise | C | 0.00 | 15,246 | 0 | 0 | |
| Nov 20 2017 | ASNS | Arsanis, Inc. | Ross Michael Jay | Director | Option Exercise | C | 0.00 | 721,402 | 0 | 0 | |
| Nov 20 2017 | ASNS | Arsanis, Inc. | Ross Michael Jay | Director | Option Exercise | C | 0.00 | 14,587 | 0 | 0 | |
| Nov 20 2017 | ASNS | Arsanis, Inc. | Ross Michael Jay | Director | Option Exercise | C | 0.00 | 690,259 | 0 | 0 | |
| Nov 20 2017 | ASNS | Arsanis, Inc. | Ross Michael Jay | Director | Option Exercise | C | 0.00 | 1,380 | 0 | 0 | |
| Nov 20 2017 | ASNS | Arsanis, Inc. | Ross Michael Jay | Director | Option Exercise | C | 0.00 | 65,287 | 0 | 0 | |
| Nov 20 2017 | ASNS | Arsanis, Inc. | Ross Michael Jay | Director | Buy | P | 10.00 | 16,552 | 165,520 | 1,868,961 | 1.9 M to 1.9 M (+0.89 %) |
| Nov 20 2017 | ASNS | Arsanis, Inc. | Ross Michael Jay | Director | Buy | P | 10.00 | 483,448 | 4,834,480 | 1,852,409 | 1.4 M to 1.9 M (+35.31 %) |
| Nov 20 2017 | ASNS | Arsanis, Inc. | Ross Michael Jay | Director | Buy | C | 0.00 | 14,789 | 0 | 1,368,961 | 1.4 M to 1.4 M (+1.09 %) |
| Nov 20 2017 | ASNS | Arsanis, Inc. | Ross Michael Jay | Director | Buy | C | 0.00 | 431,980 | 0 | 1,354,172 | 922.2 K to 1.4 M (+46.84 %) |
| Nov 20 2017 | ASNS | Arsanis, Inc. | Ross Michael Jay | Director | Buy | C | 0.00 | 4,288 | 0 | 922,192 | 917.9 K to 922.2 K (+0.47 %) |
| Nov 20 2017 | ASNS | Arsanis, Inc. | Ross Michael Jay | Director | Buy | C | 0.00 | 202,915 | 0 | 917,904 | 715 K to 917.9 K (+28.38 %) |
| Nov 20 2017 | ASNS | Arsanis, Inc. | Ross Michael Jay | Director | Buy | C | 0.00 | 2,365 | 0 | 714,989 | 712.6 K to 715 K (+0.33 %) |
| Nov 20 2017 | ASNS | Arsanis, Inc. | Ross Michael Jay | Director | Buy | C | 0.00 | 111,955 | 0 | 712,624 | 600.7 K to 712.6 K (+18.64 %) |
| Nov 20 2017 | ASNS | Arsanis, Inc. | Ross Michael Jay | Director | Buy | C | 0.00 | 6,806 | 0 | 600,669 | 593.9 K to 600.7 K (+1.15 %) |
| Nov 20 2017 | ASNS | Arsanis, Inc. | Ross Michael Jay | Director | Buy | C | 0.00 | 322,102 | 0 | 593,863 | 271.8 K to 593.9 K (+118.52 %) |
| Nov 20 2017 | ASNS | Arsanis, Inc. | Ross Michael Jay | Director | Buy | C | 0.00 | 5,219 | 0 | 271,761 | 266.5 K to 271.8 K (+1.96 %) |
| Nov 20 2017 | ASNS | Arsanis, Inc. | Ross Michael Jay | Director | Buy | C | 0.00 | 247,010 | 0 | 266,542 | 19.5 K to 266.5 K (+1,264.64 %) |
| Nov 20 2017 | ASNS | Arsanis, Inc. | Ross Michael Jay | Director | Buy | C | 0.00 | 404 | 0 | 19,532 | 19.1 K to 19.5 K (+2.11 %) |
| Nov 20 2017 | ASNS | Arsanis, Inc. | Ross Michael Jay | Director | Buy | C | 0.00 | 19,128 | 0 | 19,128 | 0 to 19.1 K |
| Jul 28 2017 | CATB | CATABASIS PHARMACE ... | ROSS MICHAEL JAY | Director | Option Exercise | A | 1.27 | 6,500 | 8,255 | 6,500 | |
| Aug 05 2016 | CATB | CATABASIS PHARMACE ... | ROSS MICHAEL JAY | Director | Option Exercise | A | 4.55 | 6,500 | 29,575 | 6,500 | |
| Jun 03 2016 | OPHT | Ophthotech Corp. | ROSS MICHAEL JAY | Director | Option Exercise | A | 0.00 | 1,750 | 0 | 1,750 | |
| Jun 03 2016 | OPHT | Ophthotech Corp. | ROSS MICHAEL JAY | Director | Option Exercise | A | 58.29 | 7,000 | 408,030 | 7,000 | |
| Jun 03 2016 | OPHT | Ophthotech Corp. | ROSS MICHAEL JAY | Director | Buy | M | 0.00 | 1,750 | 0 | 1,750 | 0 to 1.8 K |
| Jun 30 2015 | CATB | CATABASIS PHARMACE ... | ROSS MICHAEL JAY | Director | Option Exercise | A | 12.21 | 11,094 | 135,458 | 11,094 | |
| Jun 08 2015 | OPHT | Ophthotech Corp. | ROSS MICHAEL JAY | Director | Option Exercise | A | 0.00 | 1,750 | 0 | 1,750 | |
| Jun 08 2015 | OPHT | Ophthotech Corp. | ROSS MICHAEL JAY | Director | Option Exercise | A | 48.30 | 7,000 | 338,100 | 7,000 |
Page: 1